Status:
ACTIVE_NOT_RECRUITING
Effect of Subconjunctival 5-fluorouracil on the Outcome of Ahmed Valve in Neovascular Glaucoma
Lead Sponsor:
Iran University of Medical Sciences
Conditions:
Neovascular Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Neovascular glaucoma is a common and severe type of secondary closed-angle glaucoma. Topical treatments have variable effects and unfortunately often require surgery to control IOP. Although Glaucoma ...
Detailed Description
All patients with neovascular glaucoma who need surgery for the first time are included in the study. Inclusion criteria include patients over 18 years of age with neovascular glaucoma whose IOP is no...
Eligibility Criteria
Inclusion
- • Patients with diagnosis of neovascular glaucoma
Exclusion
- Patients with no light perception
- Patients aged less than 18 years old
- History of previous GDD implantation
- History of cyclodestructive procedures
- Pregnant patients
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05316142
Start Date
May 1 2024
End Date
December 1 2025
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iran University of Medical Sciences
Tehran, Iran, 1445613131